Add BrightSurf on Google Email

Monash University


New discovery could help scientists fight deadly fungal infections

Researchers have discovered how bacterial antibiotic gladiolin can disarm Candida albicans, one of the leading causes of life-threatening fungal infections. The study reveals that gladiolin can switch Candida albicans from its tissue-damaging 'hyphae' form back into its benign 'yeast' form, potentially allowing lower, less toxic doses ...

SourceMonash University·JournalCurrent Biology·TypeExperimental study·DateAug 19, 2026

Rethinking how we name and classify our human ancestors following recent evolutionary discoveries

Recent advances in human evolution challenge the current classification system, proposing a reclassification of Homo and its closely related species. The research aims to provide a more accurate and stable way to represent the complex evolutionary relationships revealed by the growing fossil record.

SourceMonash University·JournalAmerican Journal of Biological Anthropology·TypeMeta-analysis·DateAug 18, 2026

As the US recovers from its latest heatwave, a new study warns of an increase in hospitalizations for mental health issues

A new multi-country study found that sustained exposure to extreme heat is associated with an increased risk of hospitalization for mental and behavioural disorders. The study highlighted the vulnerability of older adults and residents in low-population-density areas, emphasizing the need for targeted preparedness during severe heatwaves.

SourceMonash University·JournalNature Health·TypeMeta-analysis·DateJul 10, 2026

New research makes critical discovery for the global fight against antibiotic resistance

Researchers discovered a combination regimen of two β-lactam antibiotics resulted in faster and greater killing of bacteria than using each antibiotic alone. The pairing suppressed resistance to both antibiotics, offering a promising approach to optimising and personalising antibiotic regimens against life-threatening infections.

SourceMonash University·JournalThe Lancet Microbe·TypeExperimental study·DateJun 25, 2026

Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a complex hormonal disorder impacting 1 in 8 women globally, affecting weight, metabolism, mental health, skin, and the reproductive system. The name change aims to improve diagnosis and care for this previously misunderstood condition.

SourceMonash University·JournalThe Lancet·TypeMeta-analysis·DateMay 12, 2026

Ultra-processed foods damage your focus even if you eat healthy

A study of over 2,100 Australian adults found that a daily increase in ultra-processed foods can significantly impact attention span and cognitive function. Even among those who consume a healthy Mediterranean diet, the degree of food processing plays a critical role in damaging brain health.

SourceMonash University·JournalAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·TypeData/statistical analysis·DateApr 23, 2026

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder

A new approach allows oral delivery of drugs previously requiring injection by piggybacking on natural fat absorption pathways. The medication, GlyphAllo, bypasses the liver's security checkpoint and is absorbed through the gut's lymphatic system, allowing it to enter the bloodstream directly.

SourceMonash University·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateMar 25, 2026

Can the canny tick help prevent disease like MS and cancer?

A team from Monash University Biomedicine Discovery Institute has identified a tick-derived evasin that can bind to two major classes of chemokines, representing a novel finding in the field. This discovery opens up new opportunities to develop therapies that target chemokines driving inflammatory diseases such as RA and MS.

SourceMonash University·JournalStructure·TypeExperimental study·DateFeb 27, 2026

Scientists use AI to develop a precise, safe and fast way to keep CRISPR technology in-check

Researchers at Monash University have developed an AI-powered approach to create highly accurate and specific anti-CRISPR molecules, enabling faster development of gene editing tools for various applications. This breakthrough addresses the inconsistent performance and safety risks associated with CRISPR technology.

SourceMonash University·JournalNature Chemical Biology·TypeExperimental study·DateJan 26, 2026

New discovery rewrites the rules of antigen presentation

A team of scientists has challenged long-held assumptions about how immune recognition works, discovering that lipid molecules can be displayed to T cells in a sideways orientation. This new model allows for more flexibility in the immune system's ability to survey its environment and respond to threats.

SourceMonash University·JournalNature Communications·DateJan 15, 2026

Green space to fewer hospitalizations for mental health

Higher levels of urban greenness are associated with a 7% reduction in hospital admissions for all cause mental disorders, with stronger associations for substance use disorders and psychotic disorders. The study suggests that greater exposure to greenness increases the protective effect on mental health.

SourceMonash University·JournalBMJ·TypeMeta-analysis·DateNov 6, 2025

Unlocking how viruses punch above their weight

Australian researchers discovered how rabies virus manipulates cellular processes with just a few proteins, enabling potential antiviral and vaccine development. The study reveals a new mechanism for multifunctional viral proteins to access and manipulate cell compartments.

SourceMonash University·JournalNature Communications·TypeExperimental study·DateNov 5, 2025

Researchers get wind of hydrogen’s role in the gut

Researchers have discovered that hydrogen gas produced in the gut supports beneficial bacteria and helps maintain digestion. The study found that a specific enzyme called Group B [FeFe]-hydrogenase is mainly responsible for making hydrogen, which is then used by other microbes for energy.

SourceMonash University·JournalNature Microbiology·TypeExperimental study·DateOct 23, 2025

Listening to or playing music over 75 linked to up to 39% reduction in dementia risk, study of over 10,800 finds

A Monash University study of over 10,800 older people found that listening to music or playing music can reduce dementia risk. Always listening to music was associated with a 39% reduced risk, while playing an instrument led to a 35% decrease in dementia risk

SourceMonash University·JournalInternational Journal of Geriatric Psychiatry·TypeRandomized controlled/clinical trial·DateOct 21, 2025

MS does not worsen menopause symptoms: study

A large-scale study has found that menopause is not associated with an increased risk of disability progression in women with multiple sclerosis (MS). The research, published in JAMA Neurology, used data from the MSBase Registry and followed 987 Australian women with MS for over 14 years. The study's findings suggest that menopause may...

SourceMonash University·TypeObservational study·DateSep 29, 2025

AI used to create protein that kills E. coli

Australian scientists used AI to generate a protein that can kill antibiotic-resistant bacteria like E. coli, a major step forward in combating superbugs. The new approach enables efficient de novo design of proteins with specific characteristics and functions.

SourceMonash University·JournalNature Communications·TypeExperimental study·DateJul 9, 2025

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

A Monash University-led study found that going to bed earlier is associated with higher levels of physical activity the next day. Participants who went to bed at 9pm recorded nearly 30 minutes more moderate-to-vigorous physical activity daily compared to those who stayed up until 1am.

SourceMonash University·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateJun 30, 2025

Polycystic Ovary Syndrome: Raising awareness and changing the name led by experts, health professionals and those with lived experience

A new study reveals that those affected by PCOS want a name change to overcome the misleading implication of being only an ovarian or gynaecological condition. The research, led by Monash University, involved international online surveys and face-to-face workshops, demonstrating that a name change can improve awareness, diagnosis, and ...

SourceMonash University·JournalEClinicalMedicine·TypeSurvey·DateMay 29, 2025

Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity: study

A study published in JAMA found that metformin reduced knee arthritis pain over six months in patients with symptomatic knee osteoarthritis and overweight or obesity. The treatment was shown to have a moderate effect on pain reduction, with the metformin group reporting a 31.3 point decrease compared to the placebo group.

SourceMonash University·TypeRandomized controlled/clinical trial·DateApr 24, 2025